Alert 🌍 Register Now for WTC 2025 Join your colleagues from around the world at the World Transplant Congress (WTC) — the premier international event in transplantation.

Skip to main

Join AST
Login
Keywords

Clinical Trials

Share

The clinical trials listed below are for informational purposes only and are not endorsed by the AST. More information on clinical trials can be found in our clinical trials brochure.

Clinical Trials - Recruiting

Title	Sponsor	Organ Type	Ages Accepted	Expected Completion Date
BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation	Eledon Pharmaceuticals	Kidney	18+	March 31, 2025
An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients with Advanced Cutaneous Malignancies [ARTACUS]	Replimune Inc.	All organs	18+	April 30, 2026
Tabelecleucel for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)	Atara Biotherapeutics	All organs	All ages	June 30, 2027
An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases (EBVision)	Atara Biotherapeutics	All organs	All ages	June 30, 2027

Clinical Trials - Active, Not Recruiting

Title	Sponsor	Organ Type	Ages Accepted	Expected Completion Date
Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA)	AstraZeneca	All organs		January 21, 2025
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx (ConfIdeS)	Hansa Biopharma	Kidney	18-70	June 30, 2025

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi

Sanofi